MYLK2 and amyotrophic lateral sclerosis: Accordingly, we hypothesized that the increased RLC phosphorylation by the gene therapy that overexpresses skMLCK could rescue the muscle weakness in ALS patients regardless of the variety of gene mutation, which can be a new therapeutic option of ALS treatments.